Director/PDMR Shareholding

 

TIDMGWP 
 
RNS Number : 5017N 
GW Pharmaceuticals PLC 
11 June 2010 
 

 
         GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company") 
 
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 
Porton Down, UK, 11 June 2010: GW Pharmaceuticals (AIM: GWP) hereby provides 
notification that the Company has today been notified that on 9th June Dr 
Geoffrey Guy, a Director and Executive Chairman of the Company, transferred 
11,500 ordinary shares of 0.1p each, equating to 0.01% of the issued ordinary 
share capital of the Company, into his personal pension scheme. Dr Guy also sold 
30,000 ordinary shares of 0.1p each, equating to 0.02% of the issued ordinary 
share capital of the company, at the market price of 115 pence per share. 
 
Subsequently, Dr Guy has today exercised an option to acquire 50,000 ordinary 
shares of 0.1p each, equating to 0.04% of the issued ordinary share capital at 
an exercise price of 36.2 pence per share. 
 
Following this notification Dr Guy's beneficial interest has increased to 
18,343,952 ordinary shares, amounting to 14.12% of the shares in issue. The 
total number of shares outstanding in the Company is 129,893,322 ordinary shares 
of 0.1p each. 
 
 
For further information, please contact: 
 
GW Pharmaceuticals PLC                                                +44 
(0)1980 557 000 
Adam George, Company Secretary 
 
Piper Jaffray Ltd (Nominated Adviser) 
Neil Mackison/Rupert Winckler                                          +44  (0) 
203 142 8700 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDSLLFVSRIILLII